Article History
Accepted: 31 August 2023
First Online: 3 October 2023
Declarations
:
: No specific funding for this work.
: Dr Towe received consulting fees from Boehringer Ingelheim. Dr Grom reports consulting fees and research support from Novartis, SOBI, and AB2Bio. Dr Schulert has received consulting fees from SOBI and research support from IpiNovyx.
: Dr Schulert developed initial outline. All authors wrote sections of the first draft. All authors reviewed and approved final version.
: Not applicable.
: Not applicable.
: Not applicable.